Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;152(1):75-77.e4.
doi: 10.1053/j.gastro.2016.09.041. Epub 2016 Oct 3.

Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review

Peter Broderick  1 , Sara E Dobbins  1 , Daniel Chubb  1 , Ben Kinnersley  1 , Malcolm G Dunlop  2 , Ian Tomlinson  3 , Richard S Houlston  4
Affiliations
Review

Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review

Peter Broderick et al. Gastroenterology. 2017 Jan.

Abstract

High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk. We attempted to validate the association between variants in these genes and development of CRC in a systematic review of 11 publications, using sequence data from 863 familial CRC cases and 1604 individuals without CRC (controls). All cases were diagnosed at an age of 55 years or younger and did not carry mutations in an established CRC predisposition gene. We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls. Variants that disrupted RPS20 were detected in a Finnish family with early-onset CRC (p.Val50SerfsTer23), a 39-year old individual with metachronous CRC (p.Leu61GlufsTer11 mutation), and a 41-year-old individual with CRC (missense p.Val54Leu), but not in controls. We therefore found published evidence to support the association between variants in NTHL1 and RPS20 with CRC, but not of other recently reported CRC susceptibility variants. We urge the research community to adopt rigorous statistical and biological approaches coupled with independent replication before making claims of pathogenicity.

Keywords: Colon Cancer; Exome Sequencing; Germline; Inherited.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Peter Broderick, Sara E Dobbins, Daniel Chubb, Ben Kinnersley, Malcolm G Dunlop, Ian Tomlinson, Richard S Houlston: None to declare

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. de Voer RM, Geurts van Kessel A, Weren RD, Ligtenberg MJ, et al. Gastroenterology. 2013;145:544–7. - PubMed
    1. de Voer RM, Hahn MM, et al. PLoS Genet. 2016;12:e1005880. - PMC - PubMed
    1. Nieminen TT, et al. Gastroenterology. 2014;147:595–598 e5. - PMC - PubMed
    1. Segui N, Mina LB, et al. Gastroenterology. 2015;149:563–6. - PubMed
    1. Smith CG, et al. Hum Mutat. 2013;34:1026–34. - PubMed

MeSH terms

Substances